MedTrace Logo

Impact of Okara and Bio-okara Food Product on Gut and Glycaemic Health in Middle-aged and Older Adults in Singapore

NCT03978104 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-03-24

No results posted yet for this study

Summary

This research project aims to provide the scientific findings about the beneficial effects of okara (soybean pulp) consumption on gut and glycaemic health in middle-aged and older individuals in Singapore. In addition, it aims to examine the health promoting impact of bio-transformed okara in this population. We hypothesise that consuming a habitual diet with an okara (untreated or bio-transformed) incorporated food product will improve the gut microbiome composition and will increase the production of short chain fatty acids when compared to a same diet with no okara. Okara-based food product can also improve the glycaemic response in individuals compared to a product without okara in meal tolerance test (acute).

Conditions

  • Microbiota
  • Gastrointestinal Microbiome
  • Blood Glucose
  • Aging

Interventions

DIETARY_SUPPLEMENT

Okara biscuits

Consumption of okara-enriched biscuits together with habitual diet.

DIETARY_SUPPLEMENT

Bio-okara biscuits

Consumption of bio-okara-enriched biscuits together with habitual diet. Bio-okara is a form of fermented okara.

DIETARY_SUPPLEMENT

Control biscuits

Consumption of control biscuits together with habitual diet.

Sponsors & Collaborators

Principal Investigators

  • Jung Eun Kim · National University of Singapore

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-09-28
Completion
2022-09-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03978104 on ClinicalTrials.gov